Lataa...
Retrospective Analysis of Treatment-naive Slovenian Patients with Metastatic Melanoma Treated with Pembrolizumab – Real-world Experience
BACKGROUND: Based on recent data from clinical trials, the immune checkpoint inhibitor pembrolizumab prolongs survival and has a good toxicity profile in patients with advanced or metastatic melanoma. However, the question remains whether these results are transmitted into daily clinical practice. T...
Tallennettuna:
| Julkaisussa: | Radiol Oncol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Sciendo
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087416/ https://ncbi.nlm.nih.gov/pubmed/31955148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2020-0003 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|